ReviewPharmacology & therapeutics2021

The root cause of drug resistance in HER2-positive breast cancer and the therapeutic approaches to overcoming the resistance.

Yuesheng ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.